Results 161 to 170 of about 1,505,633 (297)
Assessing serum anti-nuclear antibodies HEp-2 patterns in synucleinopathies
Immunity & AgeingThis study investigates the presence of antinuclear antibodies (ANA) in three primary synucleinopathies – Parkinson’s disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), compared to healthy controls.
Jonas Folke +10 more
doaj +1 more source
[Antinuclear antibodies]. [PDF]
Rinsho byori. The Japanese journal of clinical pathology, 1985 M, Nishikai, T, Abe
openaire +3 more sources
Advanced Science, Volume 13, Issue 2, 9 January 2026.The advent of aptamers has highlighted their potential as alternatives to antibodies, overcoming limitations of structural instability and production cost. However, conventional approaches such as SELEX remain slow and labor‐intensive. This review examines recent advances in aptamer engineering, emphasizing in vitro and AI‐driven in silico strategies ...
John V. L. Nguyen +5 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 1, January 2026.A retrospective analysis of clinical features, treatment, and outcome of 29 patients with autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A). Cerebrospinal fluid (CSF) pressure, CSF nucleated cell count, CSF protein levels, CSF chloride, serum thyroid dysfunction, and abnormal blood cytokine levels correlated with disease severity but ...
Xuewei Yang +6 more
wiley +1 more source
A Case of Atrial Septal Defect Unveiled by the Treatment for Pulmonary Arterial Hypertension
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT We present a case of a 51‐year‐old woman with atrial septal defect (ASD) masked by pulmonary arterial hypertension (PAH). Three months after PAH treatment with a combination of endothelin receptor antagonist and phosphodiesterase five inhibitor, the transthoracic echocardiography revealed left‐to‐right shunting through a secundum ASD.
Takaaki Fujii +12 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT This case of antiphospholipid syndrome, Evans syndrome, and anti‐Scl‐70 positivity (suggesting early SSc) showed marked symptom improvement with rituximab, but poor prognosis persists. Highlights the need for early diagnosis of overlapping autoimmunity, SSc complication monitoring, and optimized immunotherapy in complex cases.
Chunhua Cao +4 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT Kidney transplantation increases the survival rate of end‐stage renal disease patients; however, acute rejection and glomerulonephritis, such as the uncommon non‐lupus full‐house nephropathy (NLFHN), can lead to graft dysfunction. NLFHN exhibits a characteristic lupus immunofluorescence pattern in the absence of systemic lupus features, which ...
Tala Pourlak, Farahnoosh Farnood
wiley +1 more source
Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari +4 more
wiley +1 more source